Welcome to Cordlife Group Limited Investor Relations

We are committed to providing timely, high quality information to investors on the internet. Whether you are interested in key performance ratios, financial news and results, we hope that you will find what you need readily here.

Annual Report 2012

File size: 1.53 MB

Download Annual Report

View Flipbook Format

IR Contact

For all investor relations matters, kindly contact:

Ms. Dolores Phua / Ms. Chelsea Phua

Citigate Dewe Rogerson, i.MAGE Pte Ltd

55 Market Street, #02-01 Singapore 048941

(65) 6534 5122

Latest News

May 20, 2013

Corporate Presentation For 3Q2013 Results
May 17, 2013

Cordlife To Acquire Cord Blood And Cord Tissue Banking Businesses And Assets In India, The Philippines, Hong Kong And Indonesia
May 17, 2013

Proposed Acquisition

More News

Cordlife Group Limited was established to provide a full suite of stem cell banking services which include the collection, processing and cryopreservation storage of cord blood stem cells (Singapore and Hong Kong) and umbilical cord tissue (Hong Kong). Since its inception in 2001, our Group has grown rapidly from a fledging start-up company in Singapore into a multi-national corporation. Cordlife Group Limited is also the first private cord blood bank in Singapore to release cord blood unit for autologous use. Cordlife stores stem cells only in FDA approved, multi-compartmented cryobags - providing the safest storage method - endorsed worldwide and is the first private cord blood bank in Singapore to use the Sepax® automated stem cell processing technology to facilitate optimal stem cell recovery.